GlaxoSmithKline PLC Director/PDMR Shareholding (2280J)
April 01 2015 - 11:10AM
UK Regulatory
TIDMGSK
RNS Number : 2280J
GlaxoSmithKline PLC
01 April 2015
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
I give below details of changes in the Directors' interests in
the Ordinary Shares and American Depositary Shares ('ADSs') of
GlaxoSmithKline plc ('Company').
On 31 March 2015, the Company's Non-Executive Directors were
allocated notional Ordinary Shares at a price of GBP15.66 per
Ordinary Share, and notional ADSs at a price of $46.80 per ADS
under the share allocation arrangements for Non-Executive Directors
for the period of service from 1 January 2015 to 31 March 2015:
Non Executive Ordinary
Director Shares No. of ADSs
Sir Christopher
Gent 3,991.060
Professor Sir
Roy Anderson 458.972
Dr Stephanie Burns 486.201
Stacey Cartwright 339.240
Lynn Elsenhans 1,103.464
Sir Philip Hampton 339.240
Judy Lewent 539.049
Sir Deryck Maughan 1,479.741
Dr Daniel Podolsky 1,109.806
Urs Rohner 339.240
Tom de Swaan 419.061
Jing Ulrich 306.518
Hans Wijers 339.240
The Company and the Non-Executive Directors were informed of
these allocations on 1 April 2015.
This notification relates to transactions notified in accordance
with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
1 April 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEFLFBEZFBBBV
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024